FDA's Light Touch With Medical Apps May Let Industry Bloom
The U.S. Food and Drug Administration's hands-off approach to mobile medical apps is allowing potentially risky diagnostic tools to be sold to consumers without facing regulatory scrutiny, but stronger enforcement in...To view the full article, register now.
Already a subscriber? Click here to view full article